Trevi Therapeutics (TRVI) Debt Ratio (2020 - 2023)

Trevi Therapeutics' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.06 for Q1 2023.

• On a quarterly basis, Debt Ratio fell 86.08% year-over-year to 0.06 in Q1 2023; TTM through Mar 2023 was 0.06, a 86.08% decrease from a year earlier, with the FY2022 full-year figure at 0.07, down 80.24% from the prior year.
• Debt Ratio retreated to 0.06 in Q1 2023 per TRVI's latest filing, from 0.07 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.46 in Q1 2022 and bottomed at 0.06 in Q1 2023.
• The 4-year median for Debt Ratio is 0.3 (2020), against an average of 0.26.
• Across the five-year window, Debt Ratio jumped 83.65% in 2021 and sank 86.08% in 2023, its largest moves.
• Year by year, Debt Ratio stood at 0.3 in 2020, then grew by 27.16% to 0.38 in 2021, then sank by 80.24% to 0.07 in 2022, then dropped by 13.45% to 0.06 in 2023.
• Per Business Quant, the three latest TRVI Debt Ratio figures stand at 0.06 (Q1 2023), 0.07 (Q4 2022), and 0.08 (Q3 2022).